These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24462566)

  • 1. Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.
    Mok KY; Jones EL; Hanney M; Harold D; Sims R; Williams J; Ballard C; Hardy J
    Neurobiol Aging; 2014 Jun; 35(6):1513.e1-5. PubMed ID: 24462566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
    Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer's Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers.
    Huentelman M; De Both M; Jepsen W; Piras IS; Talboom JS; Willeman M; Reiman EM; Hardy J; Myers AJ
    Sci Rep; 2019 Jul; 9(1):9640. PubMed ID: 31270419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 21 BACE2 haplotype associates with Alzheimer's disease: a two-stage study.
    Myllykangas L; Wavrant-De Vrièze F; Polvikoski T; Notkola IL; Sulkava R; Niinistö L; Edland SD; Arepalli S; Adighibe O; Compton D; Hardy J; Haltia M; Tienari PJ
    J Neurol Sci; 2005 Sep; 236(1-2):17-24. PubMed ID: 16023140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
    Alić I; Goh PA; Murray A; Portelius E; Gkanatsiou E; Gough G; Mok KY; Koschut D; Brunmeir R; Yeap YJ; O'Brien NL; Groet J; Shao X; Havlicek S; Dunn NR; Kvartsberg H; Brinkmalm G; Hithersay R; Startin C; Hamburg S; Phillips M; Pervushin K; Turmaine M; Wallon D; Rovelet-Lecrux A; Soininen H; Volpi E; Martin JE; Foo JN; Becker DL; Rostagno A; Ghiso J; Krsnik Ž; Šimić G; Kostović I; Mitrečić D; ; Francis PT; Blennow K; Strydom A; Hardy J; Zetterberg H; Nižetić D
    Mol Psychiatry; 2021 Oct; 26(10):5766-5788. PubMed ID: 32647257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.
    Lee JH; Lee AJ; Dang LH; Pang D; Kisselev S; Krinsky-McHale SJ; Zigman WB; Luchsinger JA; Silverman W; Tycko B; Clark LN; Schupf N
    Neurobiol Aging; 2017 Aug; 56():150-158. PubMed ID: 28554490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.
    Yu Y; Jia J
    Brain Res; 2009 Feb; 1257():10-5. PubMed ID: 19124009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21.
    Mumford P; Tosh J; Anderle S; Gkanatsiou Wikberg E; Lau G; Noy S; Cleverley K; Saito T; Saido TC; Yu E; Brinkmalm G; Portelius E; Blennow K; Zetterberg H; Tybulewicz V; Fisher EMC; Wiseman FK
    J Neurosci; 2022 Aug; 42(33):6453-6468. PubMed ID: 35835549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.
    Jiang Y; Rigoglioso A; Peterhoff CM; Pawlik M; Sato Y; Bleiwas C; Stavrides P; Smiley JF; Ginsberg SD; Mathews PM; Levy E; Nixon RA
    Neurobiol Aging; 2016 Mar; 39():90-8. PubMed ID: 26923405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.
    Jiang Y; Mullaney KA; Peterhoff CM; Che S; Schmidt SD; Boyer-Boiteau A; Ginsberg SD; Cataldo AM; Mathews PM; Nixon RA
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1630-5. PubMed ID: 20080541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation for congenital heart disease in Down syndrome through analysis of partial trisomy 21 cases.
    Pelleri MC; Gennari E; Locatelli C; Piovesan A; Caracausi M; Antonaros F; Rocca A; Donati CM; Conti L; Strippoli P; Seri M; Vitale L; Cocchi G
    Genomics; 2017 Oct; 109(5-6):391-400. PubMed ID: 28648597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase.
    Solans A; Estivill X; de La Luna S
    Cytogenet Cell Genet; 2000; 89(3-4):177-84. PubMed ID: 10965118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.
    Chace C; Pang D; Weng C; Temkin A; Lax S; Silverman W; Zigman W; Ferin M; Lee JH; Tycko B; Schupf N
    J Alzheimers Dis; 2012; 28(3):601-12. PubMed ID: 22057025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a mouse model overexpressing beta-site APP-cleaving enzyme 2 reveals a new role for BACE2.
    Azkona G; Amador-Arjona A; Obradors-Tarragó C; Varea E; Arqué G; Pinacho R; Fillat C; de la Luna S; Estivill X; Dierssen M
    Genes Brain Behav; 2010 Mar; 9(2):160-72. PubMed ID: 19840121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of BACE1, BACE2 and APP in Down syndrome brains.
    Cheon MS; Dierssen M; Kim SH; Lubec G
    Amino Acids; 2008 Aug; 35(2):339-43. PubMed ID: 18163181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic signatures of Alzheimer's disease in Down Syndrome.
    Sharma A; Chunduri A; Gopu A; Shatrowsky C; Crusio WE; Delprato A
    F1000Res; 2020; 9():1299. PubMed ID: 33633844
    [No Abstract]   [Full Text] [Related]  

  • 19. Association studies using novel polymorphisms in BACE1 and BACE2.
    Nowotny P; Kwon JM; Chakraverty S; Nowotny V; Morris JC; Goate AM
    Neuroreport; 2001 Jul; 12(9):1799-802. PubMed ID: 11435901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the amyloid precursor protein locus on dementia in Down syndrome.
    Margallo-Lana M; Morris CM; Gibson AM; Tan AL; Kay DW; Tyrer SP; Moore BP; Ballard CG
    Neurology; 2004 Jun; 62(11):1996-8. PubMed ID: 15184603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.